Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
9.60
-1.41 (-12.81%)
At close: Oct 16, 2025, 3:59 PM
9.23
-3.85%
After-hours: Oct 16, 2025, 07:59 PM EDT
-12.81% (1D)
| Bid | 9.54 |
| Market Cap | 60.64M |
| Revenue (ttm) | 3.19M |
| Net Income (ttm) | -11.98M |
| EPS (ttm) | -6.5 |
| PE Ratio (ttm) | -1.48 |
| Forward PE | -5.64 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9.78 |
| Volume | 875,746 |
| Avg. Volume (20D) | 1,514,625 |
| Open | 11.29 |
| Previous Close | 11.01 |
| Day's Range | 9.58 - 11.51 |
| 52-Week Range | 1.20 - 15.50 |
| Beta | 0.23 |
| Ex-Dividend Date | n/a |
About EVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEvaxion Biotech A/S is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+37.27%
Evaxion shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 months ago
-5.92%
Evaxion shares are trading lower after the company reported a year-over-year decrease in Q2 sales results.
